Your browser doesn't support javascript.
loading
Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma.
Lim, Chwee Ming; Liou, Anthony; Poon, Michelle; Koh, Liang Piu; Tan, Lip Kun; Loh, Kwok Seng; Petersson, Bengt Fredrik; Ting, Eric; Campana, Dario; Goh, Boon Cher; Shimasaki, Noriko.
Afiliación
  • Lim CM; Department of Otorhinolaryngology-Head and Neck Surgery, Singapore General Hospital, 20 College Road, Academia, level 5, Singapore, 169856, Singapore. lim.chwee.ming@singhealth.com.sg.
  • Liou A; Duke-NUS Medical School, Singapore, Singapore. lim.chwee.ming@singhealth.com.sg.
  • Poon M; Department of Otorhinolaryngology-Head and Neck Surgery, Singapore General Hospital, 20 College Road, Academia, level 5, Singapore, 169856, Singapore.
  • Koh LP; Department of Hematology and Oncology, National University Health System, Singapore, Singapore.
  • Tan LK; National University Cancer Institute, National University Health System, Singapore, Singapore.
  • Loh KS; Department of Hematology and Oncology, National University Health System, Singapore, Singapore.
  • Petersson BF; National University Cancer Institute, National University Health System, Singapore, Singapore.
  • Ting E; Department of Hematology and Oncology, National University Health System, Singapore, Singapore.
  • Campana D; National University Cancer Institute, National University Health System, Singapore, Singapore.
  • Goh BC; National University Cancer Institute, National University Health System, Singapore, Singapore.
  • Shimasaki N; Department of Otolaryngology-Head and Neck Surgery, National University Health System, Singapore, Singapore.
Cancer Immunol Immunother ; 71(9): 2277-2286, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35098345
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Singapur
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Singapur